Avoid FDA Warning Letters: Strengthen Your MDR Process Before It’s a Problem
Medical Device Reporting (MDR) is one of the most scrutinized areas of FDA compliance and one of the most frequently mishandled. The consequences are clear in recent FDA warning letters, which continue to spotlight the same avoidable issues. These violations aren’t just paperwork errors; they can delay product distribution, damage your reputation, and result in costly regulatory actions.
The good news? These problems can be prevented with the right systems in place from the start.
What FDA Warning Letters Reveal
The FDA enforces 21 CFR Part 803 with increasing rigor, and the same MDR-related failures keep showing up:
-
- Weak or Missing Procedures: Many companies lack written MDR procedures altogether, or their procedures are missing essential definitions such as “malfunction,” “serious injury,” or “reasonably suggests.” Some firms even confuse U.S. MDR requirements with those from other countries, creating further gaps.
- Missed Red Flags: Internal processes often fail to flag events that require MDR evaluation. This leads to delayed or absent assessments and poor documentation—if any exists at all.
- Late or Missing Reports: Submissions aren’t made within the required 5- or 30-day windows, or are skipped entirely. In many cases, companies don’t even provide instructions for completing Form 3500A or ensuring all relevant data is included.
- Technical Barriers: Some firms are cited simply because they haven’t set up the required systems to submit eMDRs electronically. Without an active ESG production account, you can’t submit eMDRs, and that gap alone can lead to an FDA finding.
These issues go far beyond administrative missteps. They can lead to your device being deemed misbranded, barred from import, or subjected to seizure or civil penalties.
A Smoother Path to MDR Compliance
If this sounds daunting, you’re not alone. But these problems are solvable, and in many cases, easier to fix than you’d expect. With the right support, your team can avoid missteps and keep the focus where it belongs.
Qualomics provides Medical Device Reporting services tailored for manufacturers who want to avoid the compliance scramble and maintain confidence under FDA scrutiny. We don’t just file your reports; we help build sustainable systems that keep you compliant for the long haul.
Here’s how we support your team:
-
- Faster Submissions: Establishing an Electronic Submissions Gateway (ESG) with the FDA can take weeks. We already have an active NextGen ESG and eSubmitter setup, which means we can file your eMDRs immediately—no delay, no setup headaches.
- Reliable Reporting: As an authorized submitter, we prepare and file your mandatory FDA Form 3500A reports accurately and on time.
- End-to-End Compliance: We help you track and submit adverse events and malfunctions, keeping you aligned with every aspect of 21 CFR Part 803. Whether you’re a domestic or foreign manufacturer, our process adapts to your needs.
- Inspection-Ready Records: We provide clean, well-documented submissions that hold up to auditor scrutiny and keep your regulatory file in top shape.
- No Extra Burden on Staff: Skip the internal training and software setup. We manage the process so your team can stay focused on development, manufacturing, or quality improvement—not form chasing.
Data That Speaks for Itself
We reviewed every medical device warning letter issued by the FDA’s Center for Devices and Radiological Health (CDRH) in 2025. Out of 15 companies cited, 11 had issues related to complaints and MDRs. The themes were consistent: missing procedures, informal complaint handling, late or incomplete MDR submissions, and a lack of systemic controls. These patterns show just how common—and preventable—these problems are.
To help manufacturers benchmark and learn from these findings, we compiled all 2025 CDRH Warning Letters into one downloadable resource, including company-specific issues and key compliance takeaways. This reference is available for free and can be a valuable internal tool for quality and regulatory teams.
Download
Download the Mid-Year FDA Warning Letter Report Now
Start Clean. Stay Compliant.
Getting electronic medical device reports right doesn’t have to be complicated or expensive. The right partner can take the weight off your shoulders and help you meet FDA expectations with confidence.
Let us handle the details so you can focus on what matters most.